Here’s our fortnightly wrap of all the news driving ASX health stocks.

Of the ASX’s 133-odd small cap health stocks and of those which were trading on Wednesday, 58 were in positive territory over the last fortnight, eight were flat and 67 saw their share prices fall.

Code Name Price $ (July 8) 2 week return % 1 year return % Market cap
ARX AROA BIOSURGERY LTD 1.425 97 97 $427,606,816
ONE ONEVIEW HEALTHCARE PLC-CDI 0.07 81 -70 $13,510,496
FTT FACTOR THERAPEUTICS LTD 0.005 67 67 $5,214,178
ADO ANTEOTECH LTD 0.051 54 324 $89,821,200
SUD SUDA PHARMACEUTICALS LTD 0.047 54 -49 $8,677,518
RGS REGENEUS LTD 0.11 46 40 $36,117,248
CGS COGSTATE LTD 0.6 37 205 $97,833,472
BPH BPH ENERGY LTD 0.02 36 131 $8,870,935
DXB DIMERIX LTD 0.485 34 348 $92,942,168
IMU IMUGENE LTD 0.053 31 139 $243,428,384
CTE CRYOSITE LTD 0.18 29 260 $8,434,721
PCK PAINCHEK LTD 0.145 27 -18 $145,025,392
ALT ANALYTICA LTD 0.0025 25 -38 $8,799,031
NTI NEUROTECH INTERNATIONAL LTD 0.01 25 -47 $2,474,656
ATH ALTERITY THERAPEUTICS LTD 0.063 24 70 $49,910,184
ADR ADHERIUM LTD 0.03 20 30 $18,057,190
VLS VITA LIFE SCIENCES LTD 0.62 19 -3 $35,424,112
PIQ PROTEOMICS INTERNATIONAL LAB 0.63 19 93 $52,671,348
APH AUSTRALIAN PRIMARY HEMP LTD 0.15 19 -27 $11,160,822
NC6 NANOLLOSE LTD 0.048 17 -12 $5,076,000
ACW ACTINOGEN MEDICAL LTD 0.025 14 178 $27,905,784
1AD ADALTA LTD 0.11 13 -50 $18,034,018
MX1 MICRO-X LTD 0.175 13 -39 $64,290,212
IVX INVION LTD 0.009 13 -40 $49,505,456
ZLD ZELIRA THERAPEUTICS LTD 0.06 11 -26 $57,379,176
BD1 BARD1 LIFE SCIENCES LTD 0.031 11 -3 $74,230,440
SVA SIMAVITA LTD-CDI 0.021 11 17 $24,231,184
UCM USCOM LTD 0.215 10 54 $32,213,092
AZV AZURE HEALTHCARE LTD 0.077 10 2 $21,882,550
NSB NEUROSCIENTIFIC BIOPHARMACEU 0.235 10 -8 $18,028,454
AHX APIAM ANIMAL HEALTH LTD 0.49 9 15 $57,132,596
UBI UNIVERSAL BIOSENSORS INC-CDI 0.25 9 6 $44,392,964
ONT 1300 SMILES LTD 5.93 8 0 $140,412,816
LBT LBT INNOVATIONS LTD 0.155 7 55 $44,333,656
GMV G MEDICAL INNOVATION HOLDING 0.063 7 -58 $44,972,368
IDT IDT AUSTRALIA LTD 0.16 7 7 $38,290,084
CDX CARDIEX LTD 0.036 6 35 $29,319,550
OPT OPTHEA LTD 2.45 6 184 $662,128,128
NEU NEUREN PHARMACEUTICALS LTD 1.3 6 -11 $155,940,384
IPD IMPEDIMED LTD 0.077 6 -35 $77,619,696
BIT BIOTRON LTD 0.105 5 21 $73,702,936
S66 STAR COMBO PHARMA LTD 0.42 5 -36 $56,958,972
MEM MEMPHASYS LTD 0.115 5 120 $82,937,128
ICS ICSGLOBAL LTD 1.76 5 78 $18,663,074
IBX IMAGION BIOSYSTEMS LTD 0.054 4 24 $43,694,564
BOT BOTANIX PHARMACEUTICALS LTD 0.052 4 -78 $49,607,600
RAP RESAPP HEALTH LTD 0.155 4 -10 $105,716,728
CP1 CANNPAL ANIMAL THERAPEUTICS 0.14 4 -26 $13,037,500
CMP COMPUMEDICS LTD 0.44 4 -31 $77,065,880
BNO BIONOMICS LTD 0.068 3 72 $41,954,452
VBS VECTUS BIOSYSTEMS LTD 0.73 3 100 $16,558,371
M7T MACH7 TECHNOLOGIES LTD 0.885 2 35 $210,939,024
MDR MEDADVISOR LTD 0.485 2 40 $120,891,832
OVN OVENTUS MEDICAL LTD 0.275 2 -43 $42,724,180
SDX SIENNA CANCER DIAGNOSTICS LT 0.07 1 17 $27,659,298
OCC ORTHOCELL LTD 0.35 1 -16 $65,599,368
PBP PROBIOTEC LTD 2.01 1 27 $151,053,312
MVF MONASH IVF GROUP LTD 0.53 1 -58 $208,454,640
ACR ACRUX LTD 0.16 0 -18 $26,143,146
AC8 AUSCANN GROUP HOLDINGS LTD 0.155 0 -66 $45,971,868
SDI SDI LTD 0.71 0 -9 $83,205,872
AVE AVECHO BIOTECHNOLOGY LTD 0.008 0 75 $11,182,202
CAJ CAPITOL HEALTH LTD 0.21 0 -1 $214,745,408
CPH CRESO PHARMA LTD 0.031 0 -93 $11,357,823
BWX BWX LTD 4.16 0 97 $567,180,928
GTG GENETIC TECHNOLOGIES LTD 0.01 0 114 $82,617,264
NXS NEXT SCIENCE LTD 1.295 -1 -54 $235,102,944
PAA PHARMAUST LTD 0.195 -3 150 $58,348,268
PGC PARAGON CARE LTD 0.17 -3 -66 $57,440,500
EXL ELIXINOL GLOBAL LTD 0.17 -3 -93 $31,818,116
GSS GENETIC SIGNATURES LTD 2.59 -3 141 $362,231,936
RCE RECCE PHARMACEUTICALS LTD 1.29 -3 507 $188,140,288
PNV POLYNOVO LTD 2.3 -3 45 $1,507,280,768
MDC MEDLAB CLINICAL LTD 0.14 -3 -73 $39,154,592
THC THC GLOBAL GROUP LTD 0.27 -4 -41 $47,615,880
OSX OSTEOPORE LTD 0.6 -4 $60,738,300
OSL ONCOSIL MEDICAL LTD 0.11 -4 58 $91,146,096
PXS PHARMAXIS LTD 0.091 -4 -62 $33,596,180
MVP MEDICAL DEVELOPMENTS INTERNA 6.17 -5 15 $396,365,888
TLX TELIX PHARMACEUTICALS LTD 1.275 -5 -13 $321,239,712
NYR NYRADA INC-CDI 0.195 -5 $20,235,988
ESE ESENSE-LAB LTD-CDI 0.018 -5 -31 $9,180,684
FFC FARMAFORCE LTD 0.052 -5 -65 $6,696,091
ZNO ZOONO GROUP LTD 2.26 -6 2280 $358,311,840
IHL INCANNEX HEALTHCARE LTD 0.066 -6 -16 $50,299,632
SOM SOMNOMED LTD 1.31 -6 -33 $108,414,704
OIL OPTISCAN IMAGING LTD 0.046 -6 -6 $21,977,824
RNO RHINOMED LTD 0.075 -6 -77 $19,035,684
AMT ALLEGRA ORTHOPAEDICS LTD 0.225 -6 61 $23,488,320
CYC CYCLOPHARM LTD 1.415 -6 -5 $113,588,352
KZA KAZIA THERAPEUTICS LTD 0.51 -6 30 $48,718,160
PAR PARADIGM BIOPHARMACEUTICALS 3.08 -7 113 $685,425,792
PAB PATRYS LTD 0.012 -7 -43 $14,301,204
ICR INTELICARE HOLDINGS LTD 0.38 -7 $27,337,390
LSH LIFESPOT HEALTH LTD 0.04 -8 -47 $3,613,919
MEB MEDIBIO LTD 0.012 -8 -35 $16,171,951
HLA HEALTHIA LTD 0.93 -8 -14 $56,731,188
PYC PYC THERAPEUTICS LTD 0.115 -8 229 $337,131,456
VHT VOLPARA HEALTH TECHNOLOGIES 1.33 -8 -12 $334,040,672
MXC MGC PHARMACEUTICALS LTD 0.022 -8 -58 $34,840,288
PSQ PACIFIC SMILES GROUP LTD 1.44 -9 17 $221,062,400
AT1 ATOMO DIAGNOSTICS LTD 0.355 -9 $199,182,624
CYP CYNATA THERAPEUTICS LTD 0.635 -9 -62 $73,788,120
ATX AMPLIA THERAPEUTICS LTD 0.14 -9 74 $17,214,022
IMM IMMUTEP LTD 0.19 -10 -10 $92,649,880
RHT RESONANCE HEALTH LTD 0.145 -10 61 $62,128,352
RAC RACE ONCOLOGY LTD 0.885 -10 1157 $108,036,368
MMJ MMJ GROUP HOLDINGS LTD 0.097 -10 -64 $22,305,536
GLH GLOBAL HEALTH LTD 0.27 -10 80 $11,366,546
1ST 1ST GROUP LTD 0.036 -10 -53 $15,286,209
TD1 TALI DIGITAL LTD 0.026 -10 100 $19,481,936
JHC JAPARA HEALTHCARE LTD 0.465 -11 -51 $124,270,008
CDY CELLMID LTD 0.12 -11 -44 $15,029,624
AGH ALTHEA GROUP HOLDINGS LTD 0.32 -11 -68 $74,659,200
VTI VISIONEERING TECH-CDI 0.016 -12 -76 $13,604,244
PTX PRESCIENT THERAPEUTICS LTD 0.057 -12 28 $23,261,376
PAL PALLA PHARMA LTD 0.88 -12 -32 $110,834,216
LCT LIVING CELL TECHNOLOGIES LTD 0.014 -13 -44 $8,000,174
RHY RHYTHM BIOSCIENCES LTD 0.08 -13 -52 $10,478,000
RSH RESPIRI LTD 0.13 -13 18 $84,869,176
ANR ANATARA LIFESCIENCES LTD 0.135 -16 -48 $6,730,584
ALC ALCIDION GROUP LTD 0.13 -16 -7 $128,790,224
HCT HOLISTA COLLTECH LTD 0.066 -16 -13 $18,448,388
NOX NOXOPHARM LTD 0.315 -16 -20 $65,026,176
JHL JAYEX HEALTHCARE LTD 0.03 -17 -38 $5,290,891
DVL DORSAVI LTD 0.025 -18 -53 $5,322,833
SCU STEMCELL UNITED LTD 0.012 -20 -29 $7,699,301
EYE NOVA EYE MEDICAL LTD 0.31 -21 5 $44,516,352
BXN BIOXYNE LTD 0.011 -21 -39 $7,041,600
ANP ANTISENSE THERAPEUTICS LTD 0.082 -24 63 $39,119,052
CAN CANN GROUP LTD 0.455 -31 -77 $87,829,552
OSP OSPREY MEDICAL INC-CDI 0.03 -33 -54 $46,462,452
IMC IMMURON LTD 0.355 -56 213 $84,037,504

 

No matter which way you cut it, the last fortnight wasn’t great for markets. The Small Ords was down almost 1 per cent and the broader market was in a similar state.

Another “great rotation”, as pundits have taken to calling the big sector sell downs and buy-ins, did not favour health this time with Biotech Daily’s Top 40 index falling 2.4 per cent when compared to an ASX200 half percentage point lift in July.

However, fortune favours the bold and investors in Aroa Biosurgery (ASX:ARX) would be pleased with their first fortnight on the market, with the stock up 97 per cent from its IPO on July 24.

Aroa is treading a now familiar path with a wound care product that combines a matrix on which cells can regrow with a treatment for diabetic foot ulcers and venous leg ulcers.

The company is following in the footsteps of Avita (ASX:AVH) and Polynovo (ASX:PNV) which are both successfully treading hospital wards around the world.

Having already put its product through clinical trials and attained US Federal Drug Administration (FDA) approval, it has avoided following the other path trodden by Factor Therapeutics (ASX:FTT), which was trying to cure the same conditions — and failed badly.

However Factor is up on the list as well because its board has finally found something to buy: Brain Biosciences, a commercial-stage veterinary medical technology company in the US which is trading as LONGMILE Veterinary PET Imaging.

Chair Dr Cherrell Hirst, who led the long search for the new face of Factor, will retire at the upcoming AGM and be replaced by Dr David Brookes, a rural medicine expert and ASX biotech director.

The deal is still non-binding and subject to due diligence, but this is the first one the Factor board has felt strongly enough about to release publicly.

It’s subject to demonstrating to LONGMILE shareholders that Factor has at least $3m in cash when the deal is done and sorting out the board composition, among other things.

Health software company Oneview Healthcare (ASX:ONE) rose after saying installed live devices by the end of June were up 30 per cent on a year ago, and the June quarter saw two customers renew and one extend a contract.

Suda Pharmaceutical (ASX:SUD) finally had its day, after the Therapeutic Goods Administration (TGA) approved several months earlier than unexpected its insomnia mouth spray ZolpiMist.

Suda has been working on ZolpiMist since January 2015 when it licensed zolpidem from Amherst Pharma.

Stem cell play Regeneus (ASX:RGS) has also begun generating some interest among analysts and investors.

It recently updated its negotiating status with Japanese company Kyocera for the osteoarthritis treatment Progenza.

Under the terms of an MOU signed in March, Kyocera has exclusive rights to negotiate a commercial licence for Progenza in Japan. It was supposed to end in July but with talks moving ahead well, they agreed to extend the exclusivity period to the end of August.

And Cogstate (ASX:CGS) moved further ahead with its partnership with Eisai in Japan, which has begun building the brain performance application “Easiit”, a base element of a digital platform for dementia, that will incorporate Cogstate’s NouKNOW assessment by the end of September.